Table 4

Comparison of strategies to identify patients at risk of having a diagnosis of gastro-oesophageal cancer in the next 2 years based on the validation cohort

CriteriaRisk threshold %True negativeaFalse negativebFalse positivecTrue positivedSensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
Current dysphagian/a956 541909515643432.399.57.899.9
Current haematemesisn/a957 321124243761017.599.52.399.9
Current abdominal painn/a870 379103491 31830923.090.50.399.9
Current appetite lossn/a958 44113083256352.699.71.199.9
Current weight lossn/a952 634123690631078.099.11.299.9
Anaemian/a951 467122410 2301198.998.91.199.9
Top 10% of risk0.2875 46331586 234102876.591.01.2100.0
Top 5% of risk0.4923 34746538 35087865.496.02.299.9
Top 1% of risk2.1955 297812640053139.599.37.799.9
Top 0.5% of risk5.7958 399942329840129.999.710.899.9
  • n/a = not applicable.

  • a Criterion not met does not have disease.

  • b Criterion not met does have disease.

  • c Criterion met does not have disease.

  • d Criterion met does have disease.